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Abstract
Purpose Hemodialysis patients undergo frequent and
long visits to the clinic to receive adequate dialysis treat-
ment, medical guidance, and support. This may affect
health-related quality of life (HRQOL). Although HRQOL
is a very important management aspect in hemodialysis
patients, there is a paucity of information on the differences
in HRQOL between centers. We set out to assess the dif-
ferences in HRQOL of hemodialysis patients between
dialysis centers and explore which modiﬁable center
characteristics could explain possible differences.
Methods This cross-sectional study evaluated 570 he-
modialysis patients from 24 Dutch dialysis centers.
HRQOL was measured with the Kidney Disease Quality Of
Life-Short Form (KDQOL-SF).
Results After adjustment for differences in case-mix,
three HRQOL domains differed between dialysis centers:
the physical composite score (PCS, P = 0.01), quality of
social interaction (P = 0.04), and dialysis staff encour-
agement (P = 0.001). These center differences had a range
of 11–21 points on a scale of 0–100, depending on the
domain. Two center characteristics showed a clinical rel-
evant relation with patients’ HRQOL: dieticians’ fulltime-
equivalent and the type of dialysis center.
Conclusion This study showed that clinical relevant dif-
ferences exist between dialysis centers in multiple HRQOL
domains. This is especially remarkable as hemodialysis is a
highly standardized therapy.
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Introduction
Health-related quality of life (HRQOL) can be deﬁned as
the perceived health status in physical, social, and mental
domains [1]. Attention to and focus on HRQOL is illus-
trated by the growing number of studies on HRQOL [2].
Different clinical variables that contribute to HRQOL have
been evaluated [3], but a paucity of information remains on
the potential important role of the clinic itself.
The HRQOL of hemodialysis patients is hard-pressed.
They not only face the chronic health problems of renal
failure but also the intrusiveness of a time-consuming ther-
apy. As a result, the HRQOL of hemodialysis patients is
lower than in patients with congestive heart failure, chronic
lung disease, or cancer [4]. For in-center hemodialysis
patients, frequent and long visits to the clinic are required in
order to receive adequate dialysis treatment, medical guid-
ance,andsupport.Doesthisentwinementleadtodifferences
betweendialysiscentersinpatients’HRQOL?Andifso,can
modiﬁablecentercharacteristicsbeidentiﬁedthatarerelated
withHRQOL?Relevantdifferencesbetweendialysiscenters
have been shown for mortality [5–9] and intermediate out-
comes such as dialysis adequacy [10], hematocrit [11], and
vascular access [12]. It was our aim to assess differences in
HRQOL between dialysis centers using the Kidney Disease
Quality of Life-Short Form (KDQOL-SF), which combines
the well-known, generic Short Form 36 (SF-36) with a kid-
neydisease-speciﬁcassessmentofHRQOL[13].Oursecond
aim was to explore center characteristics that were related to
HRQOL.
Materials and methods
Patients and study design
This cross-sectional study used baseline data of the Con-
vective Transport Study (CONTRAST) [14]. The analyses
are based on 570 participating hemodialysis patients from
24 dialysis centers in The Netherlands. Centers were only
included in this analysis if at least 10 patients participated
in CONTRAST. CONTRAST is a randomized controlled
trial (ISRCTN38365125) comparing the effects of low-ﬂux
hemodialysis with online hemodiaﬁltration on all-cause
mortality and cardiovascular events, as described else-
where [14]. In short, patients were eligible if treated with
hemodialysis 2 or 3 times a week, for at least 2 months,
with a minimum dialysis urea Kt/V C 1.2, and able to
understand the study procedures. Exclusion criteria were
age\18 years, treatment by hemodiaﬁltration or high-ﬂux
hemodialysis in the 6 months preceding randomization,
severe incompliance deﬁned as non-adherence to the dial-
ysis prescription, a life expectancy\3 months due to
causes other than kidney disease, and participation in
another clinical trial. The study was conducted in accor-
dance with the Declaration of Helsinki and approved by the
medical ethics review boards of all participating hospitals.
Written informed consent was obtained from all patients
prior to enrollment.
Data collection
At baseline, standardized forms were used to collect
demographic, clinical and laboratory data. Demographic
data included age, gender, race, and educational level.
Clinical characteristics included cause of kidney failure,
diabetic state and previous cardiovascular disease, vascular
access, hemodialysis dose (single pool Kt/V urea), time on
renal replacement therapy in years, treatment time in hours,
blood pressure, body mass index (BMI), dialysis frequency,
residual kidney function, and smoking habit (yes/no).
Laboratory values were measured using standard tech-
niques. The second generation Daugirdas formula was used
to calculate single pool Kt/V for urea [15]. Residual kidney
function was expressed as estimated glomerular ﬁltration
rate (eGFR), calculated as the mean of creatinine and urea
clearance and adjusted for body surface area [16]. Center
characteristics included the number of dialysis patients per
center, nurse, and dialysis session; the proportion of
available patients enrolled in CONTRAST; frequency of
patient—physician (assistant) contacts; the fulltime-
equivalent (FTE) of nephrologists, nurses, social workers,
and dieticians; availability of exercise during dialysis (yes/
no); dialysis modalities offered (peritoneal, home, and
nocturnal dialysis); university hospital (yes/no) and regio-
nal satellite unit (yes/no).
Kidney Disease Quality of Life-Short Form
HRQOL was assessed with the validated KDQOL-SF
version 1.3 (http://gim.med.ucla.edu/kdqol/downloads/
-download.html)[ 13, 17]. It covers different domains to
face the multidimensional nature of HRQOL. The
KDQOL-SF can be split in a generic part and a disease-
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123speciﬁc part. First, the generic part is formed by the SF-36
version 1. The domains of the SF-36 can be summarized in
two summary scores, one for physical functioning (physi-
cal component summary—PCS) and one for mental func-
tioning (mental component summary—MCS). These
summaries are constructed so that a score of 50 represents
the mean of the general United States population with a
standard deviation of 10 [18]. Second, the disease-speciﬁc
part of the KDQOL-SF consists of 44 kidney disease-tar-
geted questions. The responses to these items are con-
densed in 12 domains (Table 1). These domains have a
score from 0 to 100, with higher scores indicating the
absence of problems. A difference of 5 points has been
proposed to be clinical relevant with regard to individual
domains, and a difference of 3 points with regard to the
composite scores [18, 19].
Data analysis
Patient characteristics were reported as means with standard
deviation (SD), medians with interquartile ranges, or pro-
portions when appropriate. First, differences in HRQOL
between dialysis centers were assessed, while adjusting for
case-mix covariates and the variation in the proportion of
enrolled patients. Case-mix covariates were age, gender,
race, educational status, history of cardiovascular disease,
diabetes, eGFR, and time on renal replacement therapy in
years.Second,additionaladjustmentsweremadeforprocess
variables. Process variables are characteristics that may be
inﬂuenced by patient factors as well as dialysis staff modi-
ﬁcations e.g. Kt/V, type of vascular access, hemoglobin,
albumin, and phosphate levels [20]. The relation between
center characteristics and HRQOL was evaluated indepen-
dent of case-mix covariates. Multilevel linear models or
logistic regression was applied, depending on the distribu-
tion of the residuals: parametric or non-parametric. To
facilitate logistic regression, non-parametrically distributed
domains were dichotomized using the median as cut-off
value. We used single regression analysis to account for
missingvalues[21].Themedianextentofmissingwas5%in
the HRQOL domains analyzed, 2% of case-mix covariates,
0% of center variables, and 0% of process variables. Results
were considered statistically signiﬁcant if P\0.05 (two-
tailedcomparison).AllanalyseswereconductedusingSPSS
18 (SPSS Inc. Headquarters, Chicago, Illinois, USA).
Results
Patient characteristics
The characteristics of the 570 hemodialysis patients are
summarized in Table 2. The mean age was 64 ± 14 (SD)
years, 62% of the patients were male, and 93% dialyzed 3
times per week.
Table 1 The Kidney Disease Quality of Life-Short Form (KDQOL-SF): the kidney disease-speciﬁc scales
Domains Meaning
Low High
Symptom/problem list Extremely bothered by dialysis-related symptoms such as
muscle cramps, pruritus, anorexia, and/or access problems
Not at all bothered
Effect of kidney disease
on daily life
Extremely bothered by ﬂuid and dietary restriction,
by an inability to travel and dependency on doctors
Not at all bothered
Burden of kidney disease Extremely bothered by the time consumed by dialysis,
its intrusiveness and degree burden on family
Not at all bothered
Work status Unemployed due to health Employed, health not an issue
Cognitive function Affected all of the time by inability to concentrate,
confused with poor reaction time
Not at all affected
Quality of social interaction Continual irritation and failure to get along with people
with virtual isolation
No problem, socially interactive
Sexual function Experiencing severe problems with enjoyment and arousal No problems
Sleep Very poor sleep with day time somnolence No problem with sleep
Social support Very dissatisﬁed Satisﬁed with level of social support
Dialysis staff encouragement High perceived encouragement and support Low perceived encouragement and
support
Overall health Rates health as worst possible Rates health as best possible
Patient satisfaction Very poor The best
Modiﬁed from Carmichael et al. [37]
Qual Life Res (2012) 21:299–307 301
123Dialysis center characteristics
Table 3 depicts the center characteristics (N = 24 centers).
The median number of dialysis patients that was treated in
a participating center was 109 (interquartile range 85–155)
of which 81 (64–125) were on HD or HDF. Twenty-seven
percent (17–35) of these patients were enrolled for the
current study. Based on the median FTE per patient, there
were 2.6 (2.1–3.2) nephrologists per 100 dialysis patients.
Fourteen centers (58%) offered home dialysis, and 4 (17%)
were part of a university hospital.
Quality of life differences between dialysis centers
Three HRQOL domains differed between the dialysis
centers when the variation in case-mix covariates and
proportion of enrolled patients was taken into account
(Table 4, Fig. 1): the PCS (P = 0.01), quality of social
interaction (P = 0.04), and dialysis staff encouragement
(P = 0.001). These results did not change if the differences
in HRQOL between centers were furthermore adjusted for
process variables. The differences in HRQOL had a max-
imum range of 11–21 points.
Center characteristics and quality of life
Two center characteristics showed a clinical relevant
relation with patients’ HRQOL (Table 5): dieticians’ FTE
and the type of center. Dieticians’ FTE per patient was
positively related to perceived dialysis staff encourage-
ment. Multiple HRQOL domains were better in satellite
units and worse in university hospitals.
Discussion
This study showed clinical relevant differences in the
HRQOL of hemodialysis patients between dialysis centers
in three domains: the PCS, quality of social interaction, and
Table 2 Patient characteristics (N = 570)
Demographic
Age (years) 64 ± 14
Gender (% male) 62
Caucasian (%) 86
High educational status
a (%) 24
Clinical parameters
Dialysis vintage (years) 1.9 (1.0–4.2)
Dialysis frequency (%)
29 per week 6
39 per week 93
49 per week 1
Session duration (hours) 4.0 (3.5–4.0)
spKt/V urea 1.4 ± 0.2
eGFR (mL/min/1.73 m
2)
b 2.8 (1.2–5.2)
Vascular access (% ﬁstula) 84
Body mass index (kg/m
2), after dialysis 25 ± 4
Systolic blood pressure (mmHg), before dialysis 142 ± 20
Diastolic blood pressure (mmHg), before dialysis 73 ± 11
Current smoker (%) 21
Diabetes mellitus (%) 20
History of cardiovascular disease (%) 42
Hemoglobin (mmol/L) 7.3 ± 0.8
Albumin (g/L) 36 ± 5
Calcium (mmol/L) 2.3 ± 0.2
Phosphate (mmol/L) 1.6 ± 0.5
Mean ± SD or median (interquartile range)
To convert hemoglobin in mmol/L to g/dL divide by 0.62; albumin in
g/L to g/dL, divide by 10; calcium in mmol/L to mg/dL, divide by
0.25; phosphate in mmol/L to mg/dL, divide by 0.323
eGFR estimated glomerular ﬁltration rate
a high educational status: college or university level
b In 278 patients with diuresis C100 mL/24 h (52%)
Table 3 Center characteristics (N = 24 centers)
Number of patients treated
Total 109 (85–155)
On HD or HDF 81 (64–125)
Per dialysis shift 20 (15–25)
Per nurse
2–2.5 5 (21%)
3–3.5 17 (71%)
4–4.5 2 (8%)
Setting
General hospital 18 (75%)
University hospital 4 (17%)
Regional satellite unit 2 (8%)
Offered dialysis modalities
Peritoneal dialysis 23 (96%)
Home dialysis 14 (58%)
Nocturnal dialysis 13 (54%)
FTE dialysis staff per 100 patients
Nephrologist 2.6 (2.1–3.2)
Nurse 30 (26–34)
Social worker 1.6 (1.3–1.8)
Dietician 0.9 (0.6–1.2)
Patient–physician (assistant) contacts per month
29 3 (13%)
49 18 (75%)
[49 3 (13%)
Availability of physical exercise during dialysis 20 (83%)
Center medians (interquartile ranges) or percentages
HD hemodialysis, HDF hemodiaﬁltration, FTE fulltime-equivalent
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123dialysis staff encouragement. Two center characteristics
showed a clinical relevant relation with patients’ HRQOL:
dieticians’ FTE and the type of dialysis center. Perceived
dialysis staff encouragement was higher if more dieticians
were available per patient. HRQOL was worse in patients
that dialyzed in a university hospital and better in regional
satellite units.
In the nineties, an Israeli study evaluated the differences
in generic HRQOL of dialysis patients between seven
centers in Tel Aviv with the Spitzer’s QL-index [20]. In
accordance with our results, they found that the variance in
HRQOL was not entirely explained by known case-mix
covariates. We now expand these results with more recent
data from a larger number of dialysis centers using the
KDQOL-SF, a kidney disease-speciﬁc HRQOL question-
naire that includes the SF-36.
While there is a lack of information on the differences in
HRQOL between dialysis centers, multiple studies have
been conducted on center variability in mortality [5–8].
Center characteristics that were related to improved sur-
vival were: pre-dialysis care [6], center access to trans-
plantation [5], non-proﬁt vs. for-proﬁt [5, 7], and length of
ownership [8]. It would be of interest to explore these
factors in relation to HRQOL. In the Netherlands, all
centers are non-proﬁt organizations and all have access to
renal transplantation. Differences in pre-dialysis care have
been described [22], which may lead to differences in case-
mix between centers. We did, however, adjust for case-
mix, so it is unlikely that pre-dialysis care explain our
ﬁndings.
The FTE of dieticians per patient was positively related
to perceived dialysis staff encouragement. This might
reﬂect patients’ appreciation of dietary advice [23], the
relatively large variation in dieticians’ FTE per patient, or
the positive relation between nutritional status and HRQOL
[24]. No relevant associations were found between the FTE
of other dialysis staff professionals and HRQOL. Plantinga
et al. [25] showed that less frequent patient–physician
contact in the United States was associated with lower
patient satisfaction and with a higher non-adherence to
dialysis treatment, but not with generic HRQOL, hospi-
talization, and mortality. We found no relation between the
frequency of patient–physician contact and HRQOL, which
included patient satisfaction. The discrepancy with regard
to the latter result may be caused by a somewhat larger
variation in the frequency of patient–physician contact in
US dialysis centers as compared to The Netherlands ([49
patient–physician contacts per month: 11% in US centers
Table 4 Differences in quality of life between dialysis centers (N = 24 centers)
Score P-value
Crude Adjusted
Case-mix Case-mix ? process variables
Generic domains (SF-36)
Physical component summary (PCS) 40 ± 4 0.002 0.01 0.01
Mental component summary (MCS) 51 ± 3 0.01 0.20 0.27
Kidney disease-speciﬁc domains
Symptom/problem list 80 ± 4 0.06 0.68 0.94
Effects of kidney disease on daily life 73 ± 5 0.35 0.59 0.48
Burden of kidney disease 47 ± 8 0.01 0.46 0.54
Work status 0 (0–0) 0.71 0.67 0.58
Cognitive function 80 ± 6 0.01 0.11 0.19
Quality of social interaction 83 ± 5 0.04 0.04 0.02
Sleep 62 ± 7 0.08 0.20 0.42
Social support 78 ± 7 0.44 0.33 0.18
Dialysis staff encouragement 78 ± 7 <0.001 0.001 0.001
Overall health 60 ± 4 0.04 0.98 0.76
Patient satisfaction 70 ± 5 0.99 0.99 0.99
Center mean ± SD or median (interquartile range). The P-values depict the difference in quality of life between dialysis centers as assessed with
mixed effect modeling, both crude and adjusted. Case-mix covariates were: age, gender, race, educational status, history of cardiovascular
disease, diabetes, eGFR and time on renal replacement therapy in years. Process variables were: Kt/V, type of vascular access, hemoglobin,
albumin and phosphate level. Adjusted comparisons were also corrected for the proportion of enrolled patients
Bold P-values are signiﬁcant (P\0.05)
The domains have a range from 0 to 100, with higher scores indicating a preferable health status or relative absence of problems
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123versus 13% in Dutch;[19/month: 71 vs. 88%; B19/
month: 19 vs. 0%) [25]. It should be noted that only the
frequency and not the length or quality of the contact was
studied. This might explain the absence of a relation with
HRQOL. Furthermore, the physician is engaged in more
activities than face-to-face contact to promote the care of
the individual patient [25].
HRQOL was lower in patients who received dialysis in
a university hospitals and higher in regional satellite units.
This may indicate patient selection. For instance, patients
with a higher disease burden might be urged to dialyze in
a university hospital, and healthier patients may be more
likely to visit a satellite facility. However, irrespective of
patient characteristics, type of center may still affect
HRQOL. The improved HRQOL in regional satellite units
has been attributed to improved geographic access and
reduced patients’ travel time [26, 27]. In a study that
compared in-hospital dialysis with regional satellite units
(N = 12 centers) [26], patient satisfaction was higher in
satellite units. We did not ﬁnd a difference in patient
satisfaction between in-hospital versus satellite dialysis,
but only 2 out of 24 dialysis centers were satellite units in
our analysis. A more recent analysis (N = 9 centers)
suggested that patients in satellite units experienced less
stress [27].
Adjustment for process variables did not change the
differences in HRQOL between centers. Whereas a relation
between serum albumin and HRQOL has been described;
variable results were found for Kt/V, hemoglobin, phos-
phorus, and the type of vascular access [4, 20, 24, 27–34].
If anything, these results attenuate the role of medical
interventions on HRQOL as perceived by dialysis patients.
A difference of 5 points has been proposed to be
clinical relevant with regard to individual HRQOL
domains and a difference of 3 points with regard to the
composite scores [18, 19]. Figure 1 thus indicates that the
differences in HRQOL between the centers not only have
statistical but also clinical relevance. The largest variation
was found in the perceived dialysis staff encouragement.
To evaluate this domain, the patient has to value two
statements on a scale of 1 (deﬁnitely true) to 5 (deﬁnitely
false), namely ‘‘The dialysis staff encourages me to be as
independent as possible’’ and ‘‘The dialysis staff supports
me in coping with my kidney disease’’. As health pro-
motion is the desired objective of dialysis treatment [35],
it is striking that in some centers patients experience far
less encouragement and support than in others. Dialysis
staff encouragement has been associated with better
compliance, e.g., improved adherence to dialysis treat-
ment and improved ﬂuid control [25, 36].
The variation in perceived dialysis staff encouragement
was not explained by center characteristics like differences
in the frequency of patient–physician (assistant) contacts,
the amount of patients per nurse, or the FTE of nephrolo-
gists, nurses, and social workers. Future studies should
evaluate other aspects of care to enhance center perfor-
mance on encouragement. The variation in dialysis staff
encouragement furthermore underlines the need for a reg-
ular evaluation of patient-centered care. When it is made
clear that patients’ perceptions on encouragement are
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Fig. 1 Mean quality of life scores per dialysis center. Depicted are
the mean quality of life scores per clinical center, both crude (white
circles) and adjusted for case-mix covariates (black circles) with
standard deviations. Case-mix covariates were: age, gender, race,
educational status, history of cardiovascular disease, diabetes, eGFR,
and time on renal replacement therapy in years. The domains have a
range from 0 to 100, with higher scores indicating a preferable health
status or a relative absence of problems. A difference of 5 points has
been proposed to be clinical relevant with regard to individual
domains, and a difference of 3 points with regard to the composite
scores [18, 19]. Please note that both the scales on the y-axis and the
ranking on the x-axis are different for each graph
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123relatively low, the dialysis staff may be motivated to make
an additional effort.
This study has several limitations. First, the cross-sec-
tional design excludes assessment of the temporal relation,
and second, potential signiﬁcant relations due to multi-
plicity should be taken into account. As this is an explor-
atory analysis, we refrained from an adjustment for
multiple comparisons and instead facilitated the interpre-
tation of differences found by providing quantitative
measures and focusing on clinical relevance. Finally,
although we have adjusted for a large amount of case-mix
covariates and center characteristics, bias due to unmea-
sured center- and patient-level parameters may still be
present. An example of this latter limitation might be the
unknown rate of patient agreement to participate.
In conclusion, this study showed that between dialysis
centers, relevant differences exist in HRQOL. The differ-
ences in HRQOL include both generic and disease-speciﬁc
domains like perceived dialysis staff encouragement. The
latter is a modiﬁable factor that affects compliance, which
underlines that patient encouragement should be a contin-
uous effort of the dialysis staff. Furthermore, although the
number of satellites and university hospitals was relatively
low, our results show a better HRQOL in the ﬁrst and a
worse HRQOL in the latter. Whether these ﬁndings are due
to patient selection is not readily apparent from our data
and should be a topic for further research.
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Collaborators: MG Koopman, Academic Medical Center,
Amsterdam; CJAM Konings, Catharina Hospital, Eindho-
ven; WP Haanstra, Dialysis Clinic Noord, Beilen; M Ko-
oistra, Dianet Dialysis Centers, Utrecht; T Noordzij,
Fransiscus Hospital, Roosendaal; GW Feith, Gelderse
Vallei Hospital, Ede; M van Buren, Haga Hospital, The
Hague; JJG Offerman, Isala Clinics, Zwolle; EK Hoogev-
een, Jeroen Bosch Hospital, ‘s Hertogenbosch; F de Heer,
Maasland Hospital, Sittard; PJ van de Ven, Maasstad
Hospital, Rotterdam; TK Kremer Hovinga, Martini
Table 5 Center variables and quality of life: the clinical relevant relations
b 95% CI P-value
FTE dietician per 100 patients
Dialysis staff encouragement 7.1 0.8 to 13.5 0.03
University hospital
Mental component summary (MCS) -3.7 -7.1 to -0.3 0.03
Effects of kidney disease on daily life -7.0 -11.4 to -2.6 0.002
Burden of kidney disease -11.5 -18.9 to -4.1 0.004
Cognitive function -8.0 -13.7 to -2.2 0.01
Quality of social interaction -5.7 -10.6 to -0.8 0.02
Social support -8.0 -14.0 to -2.0 0.01
Overall health -5.1 -9.5 to -0.7 0.03
Satellite unit
Physical component summary (PCS) 8.4 2.3 to 14.6 0.01
Symptom/problem list 8.9 1.9 to 15.8 0.01
Effects of kidney disease on daily life 9.3 1.0 to 17.7 0.03
Burden of kidney disease 15.1 1.6 to 28.6 0.03
Sleep 11.1 1.6 to 20.7 0.02
Depicted are the clinical relevant relations between center variables (determinant) and quality of life domains (outcome) i.e. b C 3 for composite
summaries and C5 for individual domains. All comparisons were analyzed with multilevel linear models and adjusted for case-mix covariates.
The b shows the amount of change in quality of life if the FTE of dieticians increases with 1 per 100 patients or if patients in a university or
satellite dialysis center are compared with a non-university or non-satellite center
CI conﬁdence interval, FTE fulltime-equivalent
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123Hospital, Groningen; WA Bax, Medical Center Alkmaar,
Alkmaar; JO Groeneveld, Onze Lieve Vrouwe Gasthuis,
Amsterdam; ATJ Lavrijssen, Oosterschelde Hospital,
Goes; AM Schrander-Van der Meer, Rijnland Hospital,
Leiderdorp; LJM Reichert, Rijnstate Hospital, Arnhem; J
Huussen, Slingeland Hospital, Doetinchem; PL Rensma, St
Elisabeth Hospital, Tilburg; Y Schrama, St Fransiscus
Gasthuis, Rotterdam; HW van Hamersvelt, University
Medical Center St Radboud, Nijmegen; WH Boer, Uni-
versity Medical Center Utrecht, Utrecht; WH van Kuijk,
VieCuri Medical Center, Venlo; MG Vervloet, VU Medi-
cal Center, Amsterdam; and IMPMJ Wauters, Zeeuws-
Vlaanderen Hospital, Terneuzen.
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